Regulus Therapeutics, Inc.
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop...
Neurocrine Biosciences, Inc.
• Designing and executing interventional and observational research studies consistent with overall payer strategies.
• Building and refining pharmacoeconomic models (e.g. budget impact models).
Direct Customer Interactions:...